LEADER 01466nam  2200385Ia 450 
001 9910698929103321
005 20090716152724.0
035   $a(CKB)5470000002398587
035   $a(OCoLC)426052269
035   $a(EXLCZ)995470000002398587
100   $a20090716d2005      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry and FDA staff$b[electronic resource] $eapplication user fees for combination products
210  1$a[Rockville, MD] :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of Combination Products,$d[2005]
215   $a15 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on July 17, 2009).
300   $a"April 2005".
517   $aGuidance for industry and FDA staff 
606   $aUser charges$xGovernment policy$zUnited States
606   $aDrug approval$xGovernment policy$zUnited States
606   $aChemotherapy, Combination
615  0$aUser charges$xGovernment policy
615  0$aDrug approval$xGovernment policy
615  0$aChemotherapy, Combination.
712 02$aUnited States.$bFood and Drug Administration.$bOffice of Combination Products.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698929103321
996   $aGuidance for industry and FDA staff$93451983
997   $aUNINA